Home › Functietitels › Manager, Regulatory Affairs
Manager, Regulatory Affairs: H-1B-salarissen
72 arbeidsvoorwaardenaanvragen gebruikten de functietitel Manager, Regulatory Affairs. Mediaan aangeboden basissalaris $132.288; middenhelft $119.706–$144.000.
Aanvragen (LCA's)72
Mediaan aangeboden salaris$132.288
Middelste helft van salarissen$119.706–$144.000
10e–90e percentiel$110.000–$159.500
Immigratieadvocaat, recruiter of werkgever? Laat uw dienst bovenaan deze pagina zien — $99 voor 30 dagen →
Werkgevers
| Werkgever | LCAs | Mediaan salaris |
|---|
| Edwards Lifesciences LLC | 7 | $132.288 |
| Teva Pharmaceuticals USA, Inc. | 6 | $127.182 |
| ReCor Medical, Inc. | 2 | $150.000 |
| Collegium Pharmaceutical, Inc. | 2 | $158.121 |
| Thermo Fisher Scientific Inc. | 2 | $122.377 |
| Lonza Houston Inc | 2 | $137.511 |
| Becton, Dickinson and Company | 2 | $144.000 |
| Cardinal Health | 2 | $137.002 |
| Eikon Therapeutics, Inc. | 2 | $124.654 |
| Terumo Medical Corporation | 2 | $133.832 |
| Xiromed, LLC | 2 | $125.169 |
| Verastem Inc. | 1 | $133.848 |
| Karyopharm Therapeutics Inc. | 1 | $120.000 |
| Eugia US Manufacturing LLC | 1 | — |
| Emergent Travel Health Inc. | 1 | $136.490 |
| Amarin Pharma Inc. | 1 | $175.000 |
| Bavarian Nordic Inc. | 1 | $134.430 |
| Daiichi Sankyo, Inc. | 1 | $135.000 |
| BeiGene USA, Inc. | 1 | $130.000 |
| McKesson Corporation | 1 | $129.377 |
| Baxter Healthcare Corporation (USA) | 1 | $110.000 |
| Chanel, Inc. | 1 | $110.000 |
| Masimo Corporation | 1 | $127.192 |
| Alvogen Group Inc. | 1 | $142.000 |
| Alnylam US, Inc. | 1 | $140.000 |
| Emergent Product Development Gaithersburg Inc. | 1 | $140.000 |
| Cosette Pharmaceuticals, Inc. | 1 | $85.000 |
| Zydus Pharmaceuticals USA, Inc. | 1 | $112.000 |
| iRhythm Technologies, Inc. | 1 | $187.959 |
| Riconpharma, LLC | 1 | $125.000 |
| Gilead Sciences, Inc. | 1 | $157.991 |
| Helen of Troy Nevada Corporation | 1 | $115.000 |
| Hikma Pharmaceuticals USA Inc. | 1 | $120.453 |
| Bausch Health US, LLC | 1 | $112.235 |
| Apellis Pharmaceuticals Inc. | 1 | $148.384 |
| ChemWerth Inc. | 1 | $113.443 |
| FUJIFILM Sonosite, Inc. | 1 | $137.898 |
| Relay Therapeutics, Inc. | 1 | $100.000 |
| Penumbra, Inc. | 1 | $123.469 |
| Alphatec Spine Inc. | 1 | $150.000 |
| Gen-Probe Incorporated | 1 | $114.691 |
| Syner-G BioPharma Group LLC | 1 | $122.926 |
| Eugia US LLC | 1 | $124.000 |
| AdvaGen Pharma, Ltd. | 1 | $145.000 |
| Synaptic Medical Corp. | 1 | $180.000 |
| Intuitive Surgical Operations, Inc. | 1 | $213.428 |
| CRISPR Therapeutics, Inc. | 1 | $1.524.000 |
| St. Jude Medical, Cardiology Division, Inc. | 1 | $155.000 |
| Revolution Medicines, Inc. | 1 | $159.500 |
| Navinta III Inc. | 1 | $90.000 |
| Aveva Drug Delivery Systems, Inc. | 1 | $110.000 |
| West Pharmaceutical Services, Inc. | 1 | $119.350 |
Per loonniveau
| Loonniveau | Mediaan salaris |
|---|
| Niveau I (instap) | $124.004 |
| Niveau II (gekwalificeerd) | $134.430 |
| Niveau III (ervaren) | $136.000 |
| Niveau IV (volledig bekwaam) | $126.672 |
Het Department of Labor stelt vier heersende loonniveaus vast voor elk beroep en gebied, van Niveau I (instap) tot Niveau IV (volledig bekwaam). De werkgever kiest het niveau dat bij de vereisten van de baan past.
Per boekjaar
| Boekjaar | LCAs | Mediaan salaris |
|---|
| FY2023 | 16 | $133.865 |
| FY2024 | 18 | $128.148 |
| FY2025 | 25 | $132.288 |
| FY2026 | 12 | $135.532 |
Steden
- Irvine, CA8
- East Windsor, NJ3
- Parsippany, NJ3
- Palo Alto, CA2
- Redwood City, CA2
- Bridgewater, NJ2
- Stoughton, MA2
- San Diego, CA2
- Houston, TX2
- Santa Ana, CA2
- Dublin, OH2
- Cambridge, MA2
- Somerset, NJ2
- West Chester, PA2
- Carlsbad, CA2
- Florham Park, NJ2
- Needham, MA1
- Newton, MA1
- Rochester, NY1
- Basking Ridge, NJ1
- Emeryville, CA1
- Irving, TX1
- Thousand Oaks, CA1
- Piscataway, NJ1
- New York, NY1
- Arlington Heights, IL1
- Gaithersburg, MD1
- South Plainfield, NJ1
- Pennington, NJ1
- San Francisco, CA1
Salarissen zijn het laagste eind van het aangeboden loon per aanvraag, omgerekend naar een jaarbedrag; statistieken gebruiken alleen gecertificeerde fulltime aanvragen. Een LCA is geen visumgoedkeuring en één LCA kan meerdere functies dekken. Bron: U.S. Department of Labor, OFLC LCA Disclosure Data, boekjaren 2023–2026 (laatste beslissing 30 jun. 2026).